The Valley Desk

NCT06218628 · Interventional trial

Pacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 Inhibition

Overall registry status Recruiting

Phase 1

Conditions Chronic Myelomonocytic Leukemia, Essential Thrombocytosis, Polycythemia Vera, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Primary Myelofibrosis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov